Copyright
©The Author(s) 2020.
World J Hepatol. Nov 27, 2020; 12(11): 1020-1030
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.1020
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.1020
Hazard ratio | 95%CI | P value | |
Age > 60 years old | 0.862 | 0.708-1.050 | 0.14 |
Sex (Male) | 1.071 | 0.863-1.328 | 0.54 |
Race | 0.07 | ||
API vs black | 0.654 | 0.452-0.9481 | |
API vs Hispanic | 0.838 | 0.595-1.180 | |
API vs white | 0.727 | 0.555-0.9521 | |
Black vs Hispanic | 1.280 | 0.884-1.852 | |
Black vs white | 1.111 | 0.819-1.506 | |
Hispanic vs white | 0.868 | 0.660-1.140 | |
AJCC stages | < 0.01 | ||
Stage I/II vs unknown | 0.547 | 0.390-0.7681 | |
Stage III/IV vs unknown | 0.709 | 0.509-0.9881 | |
Stage I/II vs III/IV | 0.772 | 0.571-1.042 | |
Metastasis | 1.229 | 0.918-1.645 | 0.17 |
Tumor size < 50 mm | 0.704 | 0.545-0.9081 | < 0.01 |
LRT | 1.782 | 1.134-2.8011 | 0.01 |
Resection | 2.770 | 2.137-3.5901 | < 0.01 |
Transplant | 4.247 | 2.809-6.5421 | < 0.01 |
- Citation: Sempokuya T, Wien EA, Pattison RJ, Ma J, Wong LL. Factors associated with 5-year survival of combined hepatocellular and cholangiocarcinoma. World J Hepatol 2020; 12(11): 1020-1030
- URL: https://www.wjgnet.com/1948-5182/full/v12/i11/1020.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i11.1020